call 1800 257 600 email [email protected]

Carney Triad

Carney triad is a rare is a rare genetic condition that increases the risk of developing certain types of cancer, most notably paragangliomas and gastrointestinal stromal tumours (GIST). Paragangliomas are classified as neuroendocrine tumours (NETs).

NETS are a complex group of tumours that develop in the neuroendocrine system, which is responsible for regulating important bodily functions such as heart rate, blood pressure and metabolism. They most commonly develop in the gastro-intestinal tract, pancreas, and the lungs; however, they can develop anywhere in the body. These tumours develop from neuroendocrine cells, which are responsible for receiving signals from the nervous system and producing hormones and peptides (small proteins) in response.

Familial cancer syndromes, also known as hereditary cancer syndromes, are rare conditions that cause an increased risk of cancer as the result of inherited genetic mutations in certain cancer-related genes. They can affect both adults and children, however they generally develop in people at a younger age than normal. While familial cancer syndromes are not classified as cancer, they are equally as severe and can be life-threatening as they are associated with the development of various tumours throughout the body. Having a familial cancer syndrome does not guarantee the development of cancer, however the risk of developing cancer is higher than those who do not have a familial cancer syndrome.

Carney triad is often confused with the conditions Carney-Stratakis syndrome (a rare and potentially related syndrome that causes the development of paragangliomas and GISTS only) and Carney complex (a rare and unrelated syndrome classified as a type of multiple endocrine neoplasia syndrome). While the three syndromes share a similar name, it is important to recognise they are different conditions. For more information on either Carney-Stratakis syndrome or Carney complex, please refer to their respective pages on the Rare Cancers Australia knowledgebase.

Carney triad is slightly more common in females, and is generally diagnosed around the age of 20. However, anyone can develop this disease.

Types of Tumours Associated with Carney Triad

Carney triad is associated with the development of:

Treatment

When cancers are detected, they are staged and graded based on size, metastasis (whether the cancer has spread to other parts of the body) and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, each patient with Carney triad will present with a unique disease behaviour, with varying cancer locations and symptoms. As such, there is no one treatment method that will work for everyone, and there is no standard staging system for this disease. Instead of staging and grading, your doctor will recommend a treatment plan based on the following factors:

  • Type of cancer present.
  • Cancer location.
  • Whether or not the cancer has metastasised.
  • Your age.
  • General health.
  • Your treatment preferences.

Your doctor may also recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment options for tumours associated with Carney triad may include:

  • Surgery to remove as much of the tumour(s) as possible – this will vary based on tumour type and location.
  • Radiation therapy.
  • Chemotherapy.
  • Clinical trials.
  • Palliative care.

Cancer Screening

Once a diagnosis of Carney triad has been confirmed, implementing a targeted screening plan becomes essential due to the increased risk of developing certain cancers.  The content of this plan will vary from person to person based on the genetic mutation involved, your family’s history of cancer and the types of cancers that may be present. It will also outline the routine tests you should have and how regularly you should have them.

Screening options for Carney triad may evolve as new technologies are developed and our understanding of the condition grows. It is essential to discuss your individual circumstances with your healthcare team to determine the most appropriate screening plan for you.

Risk factors

Because of how rare Carney triad is, there has been limited research done into the risk factors of this disease.

Symptoms

The symptoms of Carney triad often vary by the type(s) of tumours present. General symptoms of Carney triad may include:

  • Hypertension.
  • Headaches.
  • Unexplainable sweatiness.
  • Tachycardia.
  • Blood in stool, sputum and/or vomit.
  • Abdominal pain and/or mass.
  • Bloating.
  • Fatigue.
  • Difficulties/pain when swallowing.
  • Unexplainable weight loss/loss of appetite.
  • Nausea and/or vomiting.
  • Anaemia.
  • Persistent cough (lasting more than a few weeks).
  • Dyspnea.
  • Persistent chest infections.
  • Chest and/or shoulder pain.
  • Hoarse voice.
  • Wheezing.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have Carney triad, they may order some of the following tests to confirm the diagnosis and refer you to a specialist for treatment. The tests required for diagnosis will often vary based on the symptoms present, and where the tumour(s) are suspected to be located.

  • Physical examination.
  • Genetic testing.
  • Endocrine studies.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
    • PET (positron emission tomography) scan.
  • Exploratory procedures, such as an endoscopy.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.